首页 › 基金 › Defilade Capital Management, L.P. › RVMD
Defilade Capital Management, L.P. 对 RVMD 的持仓历史
REVOLUTION MEDICINES INC · 医疗保健
Defilade Capital Management, L.P. 在 Q3 2026 的 13F 申报中披露持有 RVMD(REVOLUTION MEDICINES INC)71,186 股,市值约 US$14.6M,约占其申报组合的 2.44%,在其申报持仓中市值排名第 20 位。 Defilade Capital Management, L.P. 最近 4 个申报季度中有 4 个季度披露了 RVMD 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Defilade Capital Management, L.P. 对 RVMD 的持仓演变
Defilade Capital Management, L.P. 于 Q4 2025 首次披露 RVMD 持仓:363,454 股(约 US$28.9M)。 该持仓在 Q1 2026 达到峰值 315,972 股,市值约 US$30.7M。 在 4 次申报中,Defilade Capital Management, L.P. 0 次增持、3 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 71,186 股、市值约 US$14.6M,环比减持 -11,641 股。。 持仓曾出现大幅变动:Q2 2026 减持约 74% (随后一个季度股价上涨 10%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 363.45K | $28.95M | 新进 |
| Q1 2026 | 315.97K | $30.73M | 减持 |
| Q2 2026 | 82.83K | $15.51M | 减持 |
| Q3 2026 | 71.19K | $14.61M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RVMD 与 13F 数据
RVMD(REVOLUTION MEDICINES INC)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 RVMD,申报仓位最大的包括:FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.75B), 法拉龙资本管理 (US$2.54B), BAKER BROS. ADVISORS LP (US$2.18B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RVMD 的基金
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.42M 股 · $2.75B · Q3 2026
- 法拉龙资本管理 13.55M 股 · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 10.64M 股 · $2.18B · Q3 2026
- Darwin Global Management, Ltd. 10.63M 股 · $2.18B · Q3 2026
- Nextech Invest Ltd. 7.60M 股 · $1.56B · Q3 2026
- 骏利亨德森集团 7.57M 股 · $1.56B · Q3 2026
- Paradigm Biocapital Advisors LP 6.22M 股 · $1.28B · Q3 2026
- Alphabet Inc. 2.67M 股 · $548.85M · Q3 2026
- Casdin 资本 2.58M 股 · $529.02M · Q3 2026
- BVF INC/IL 2.46M 股 · $505.05M · Q3 2026
- Assenagon Asset Management S.A. 2.18M 股 · $447.71M · Q3 2026
- Avoro Capital Advisors LLC 2.15M 股 · $440.28M · Q3 2026
更多关于 Defilade Capital Management, L.P.
常见问题
How long has Defilade Capital Management, L.P. held RVMD?
Defilade Capital Management, L.P. has disclosed RVMD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Defilade Capital Management, L.P.'s current position in RVMD?
As of Q3 2026, Defilade Capital Management, L.P. holds 71.19K shares of RVMD (REVOLUTION MEDICINES INC), valued at $14.61M, representing 2.44% of its reported portfolio and ranking #20.
Has Defilade Capital Management, L.P. been buying or selling RVMD?
In the latest 13F filing (Q3 2026), Defilade Capital Management, L.P. reduced its position in RVMD. The position peaked in Q1 2026 at 315.97K shares.
Which other funds hold RVMD?
Other major institutional holders of RVMD include FARALLON CAPITAL MANAGEMENT, L.L.C., 法拉龙资本管理, BAKER BROS. ADVISORS LP, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.